Amanta Healthcare announces price band for its IPO. Check details

Amanta Healthcare has fixed the price band for its upcoming IPO at Rs 120–126 per equity share. The book-building issue of 1 crore equity shares will open for subscription on September 1 and close on September 3. The basis of allotment is expected on September 4, with a tentative listing date of September 8 on both BSE and NSE.

Issue structure

The IPO is entirely a fresh issue of 1 crore shares. As per SEBI regulations, up to 50% of the net offer will be reserved for Qualified Institutional Buyers (QIBs), at least 35% for retail investors, and not less than 15% for Non-Institutional Investors (NIIs).

Company background

Founded in 1994, Amanta Healthcare develops, manufactures, and markets sterile liquid formulations and medical devices. Its product portfolio includes IV fluids, diluents, ophthalmic solutions, respiratory care products, irrigation solutions, and eye lubricants.


The company leverages advanced Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) technologies for packaging. Amanta markets more than 45 generic products in India through a network of 320 distributors and stockists, while also exporting branded products to 21 countries across Africa, Latin America, the UK, and other regions.

Financial performance

For FY25, the company reported revenue of Rs 276.09 crore, slightly lower than Rs 281.61 crore in FY24. However, profit after tax surged 189% year-on-year to Rs 10.5 crore, compared with Rs 3.63 crore in the previous fiscal.

Use of proceeds

The funds raised will be deployed towards capital expenditure, including Rs 70 crore for setting up a new SteriPort manufacturing line at Hariyala, Gujarat, and Rs 30.13 crore for a new SVP manufacturing line at the same site. The remaining proceeds will be used for general corporate purposes.

Beeline Capital Advisors is the book-running lead manager to the issue, while MUFG Intime India is the registrar.